The nation of Zimbabwe has turned down a substantial US healthcare agreement worth $367m (272 million pounds) over five years over the United States' insistence on sensitive data.
This move became public following a government memo from December was leaked, which showed President Emmerson Mnangagwa believed the agreement was "skewed".
A government spokesperson later explained that the United States was requesting health data for scientific study and commercial purposes while was not willing to share the benefits from future treatments.
"We will now turn to the challenging and unfortunate task of scaling back our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the United States had furnished more than $1.9bn in health funding to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has called for more negotiations to secure a agreement acceptable to both sides so the country's vital HIV programme can be sustained.
Broader Background
Zimbabwe's decision comes after a similar case in Kenya, where a high court blocked a similar health funding agreement after concerns were filed about the safety of citizens' health data.
Since returning to office last year, US President Donald Trump has reduced overseas assistance and closed the US Agency for International Development (USAID).
USAID had overseen aid for the US government, but Trump claimed its expenditure was "inefficient" and his government was seeking direct bilateral agreements to boost transparency and responsibility.
As per statements, 16 African countries have so far agreed to these new agreements, representing more than $18.3bn in committed funds.
Details of the Rejected Agreement
The funds for Zimbabwe was intended to supported "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We are confident this partnership would have delivered significant benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children presently on HIV treatment via US-supported programmes," Tremont commented.
However, official spokesman Nick Mangwana said the proposed deal was "unfair".
"Our nation was requested to provide its genetic material and health information for a long time, with no corresponding guarantee of access to any medical innovations – such as vaccines, diagnostics, or treatments – that could be developed from that shared data," he stated.
"In essence, our country would provide the basic resources for medical research without any certainty that the end products would be accessible to our population should a new health crisis arise."
National Interest and International Frameworks
Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one health agreements were undermining structures already established via the global organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing system created to manage potential global health emergencies.
"This system is intended to ensure that when a nation contributes its data, the benefits – such as vaccines and treatments – are shared equitably, not monopolised exclusively by those with the resources to create them."
Zimbabwe's reservations over the US deal "should not be misconstrued as opposition to America," he added.
"We are open to further dialogue with our American counterparts on how subsequent co-operation might be structured in a way that honours the independence and dignity of both nations."
Health Experts Response
Medical experts stated it recognised the government's concerns, but urged that negotiations should continue since much of the country's HIV programmes relied on foreign aid.
"Where specific concerns arise, including those relating to data governance or implementation frameworks, these can frequently be resolved via technical clarification and negotiated safeguards," it added.
The halted deal emphasises the complex tensions between receiving crucial foreign assistance and safeguarding local interests in an ever more data-driven world.